# Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

> **NCT04552418** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Potato starch

## Key facts

- **NCT ID:** NCT04552418
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-02
- **Primary completion:** 2023-01-24
- **Final completion:** 2023-01-24
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04552418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04552418, "Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04552418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*